scholarly journals Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study

2016 ◽  
Vol 16 (4) ◽  
pp. 441-448 ◽  
Author(s):  
Elizabeth H Byrne ◽  
Melis N Anahtar ◽  
Kathleen E Cohen ◽  
Amber Moodley ◽  
Nikita Padavattan ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0137352 ◽  
Author(s):  
Molly Rosenberg ◽  
Audrey Pettifor ◽  
Nadia Nguyen ◽  
Daniel Westreich ◽  
Jacob Bor ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Smritee Dabee ◽  
Ramla F. Tanko ◽  
Bryan P. Brown ◽  
Rubina Bunjun ◽  
Christina Balle ◽  
...  

BackgroundCervicovaginal inflammation, bacterial microbiota and hormonal contraceptives all influence sexual and reproductive health. To date, the effects of intramuscular depo-medroxyprogesterone acetate (DMPA-IM) versus injectable norethisterone enanthate (NET-EN) on vaginal microbiota or cytokines have not been compared back-to-back, although in-vitro data suggest that DMPA-IM and NET-EN have different pharmacokinetic and biologic activities. This study aimed at comparing the effects of DMPA-IM versus NET-EN initiation on cervicovaginal cytokines and microbiota in women at high risk for sexually transmitted infections (STIs) assigned to the respective contraceptives.MethodsWe collected socio-demographic characteristics and vaginal samples from women initiating DMPA-IM (ECHO Trial; n = 53) and NET-EN (UChoose Trial; n = 44) at baseline and after two consecutive injections to assess cytokine concentrations by Luminex, vaginal microbiota by 16S rRNA gene sequencing, STIs, bacterial vaginosis (BV) and candidiasis.ResultsCytokine concentrations did not change significantly after initiating DMPA-IM or NET-EN, although NET-EN versus DMPA-IM-associated profiles were distinct. While the abundance of bacterial taxa associated with optimal and non-optimal microbiota fluctuated with DMPA-IM use, overall community composition did not significantly change with either contraceptive. HSV-2 serology, chlamydial infection, gonorrhoea and candidiasis did not influence the associations between contraceptive type and cervicovaginal cytokines or microbiota.ConclusionsBoth DMPA-IM and NET-EN use did not lead to broad inflammatory or microbiota changes in the female genital tract of sub-Saharan African women. This suggests that NET-EN is likely a viable option for contraception in African women at high risk of BV and STIs.


Author(s):  
Andréa Maria Novaes Machado ◽  
Morgani Rodrigues ◽  
Helena Malvezzi ◽  
Carla de Azevedo Piccinato ◽  
Nelson Hamerschlak ◽  
...  

2013 ◽  
Vol 40 (7) ◽  
pp. 601-606 ◽  
Author(s):  
Frank Tanser ◽  
Kyle G. Jones ◽  
Johannes Viljoen ◽  
John Imrie ◽  
Erofili Grapsa ◽  
...  

2014 ◽  
Vol 30 (S1) ◽  
pp. A230-A231
Author(s):  
Kathleen E. Doherty ◽  
Melis Anahtar ◽  
Musie Ghebremichael ◽  
Christina Thogabekale ◽  
Nikita Padavattan ◽  
...  

2016 ◽  
Vol 73 (4) ◽  
pp. 438-445 ◽  
Author(s):  
Magdalena E. Sobieszczyk ◽  
Lise Werner ◽  
Koleka Mlisana ◽  
Nivashnee Naicker ◽  
Addi Feinstein ◽  
...  

2020 ◽  
Vol 16 (12) ◽  
pp. e1009097
Author(s):  
Laura Noël-Romas ◽  
Michelle Perner ◽  
Refilwe Molatlhegi ◽  
Christina Farr Zuend ◽  
Amanda Mabhula ◽  
...  

Alterations to the mucosal environment of the female genital tract, such as genital inflammation, have been associated with increased HIV acquisition in women. As the microbiome and hormonal contraceptives can affect vaginal mucosal immunity, we hypothesized these components may interact in the context of HIV susceptibility. Using previously published microbiome data from 685 women in the CAPRISA-004 trial, we compared relative risk of HIV acquisition in this cohort who were using injectable depot medroxyprogesterone acetate (DMPA), norethisterone enanthate (NET-EN), and combined oral contraceptives (COC). In women who were Lactobacillus-dominant, HIV acquisition was 3-fold higher in women using DMPA relative to women using NET-EN or COC (OR: 3.27; 95% CI: 1.24–11.24, P = 0.0305). This was not observed in non-Lactobacillus-dominant women (OR: 0.95, 95% CI: 0.44–2.15, P = 0.895) (interaction P = 0.0686). Higher serum MPA levels associated with increased molecular pathways of inflammation in the vaginal mucosal fluid of Lactobacillus-dominant women, but no differences were seen in non-Lactobacillus dominant women. This study provides data suggesting an interaction between the microbiome, hormonal contraceptives, and HIV susceptibility.


Sign in / Sign up

Export Citation Format

Share Document